NEWS RELEASE 01.13.2022 Arrow

TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMA

NEWS RELEASE 01.11.2022 Arrow

AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICS

NEWS RELEASE 01.10.2022 Arrow

AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE THAT KARMA BIOTECHNOLOGIES WILL RECEIVE THE SECOND AMGEN GOLDEN TICKET

NEWS RELEASE 01.10.2022 Arrow

EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

NEWS RELEASE 01.06.2022 Arrow

AMGEN TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

NEWS RELEASE 01.06.2022 Arrow

Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement

Earnings

Show all
ALL RESULTS 

Data as of:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

MORE STOCK